000 01555 a2200409 4500
005 20250514232527.0
264 0 _c20051205
008 200512s 0 0 eng d
022 _a1352-0504
024 7 _a10.1111/j.1365-2893.2005.00610.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTedaldi, E M
245 0 0 _aEffect of IL-2 on hepatitis C virus RNA levels in patients co-infected with human immunodeficiency virus receiving HAART.
_h[electronic resource]
260 _bJournal of viral hepatitis
_cJul 2005
300 _a414-20 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAntiretroviral Therapy, Highly Active
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aAspartate Aminotransferases
_xblood
650 0 4 _aCD4 Lymphocyte Count
650 0 4 _aFemale
650 0 4 _aHIV
_xdrug effects
650 0 4 _aHIV Infections
_xcomplications
650 0 4 _aHepacivirus
_xdrug effects
650 0 4 _aHepatitis C
_xcomplications
650 0 4 _aHumans
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aRNA, Viral
_xblood
700 1 _aChen, L
700 1 _aMarkowitz, N
700 1 _aKelly, L
700 1 _aAbrams, D
773 0 _tJournal of viral hepatitis
_gvol. 12
_gno. 4
_gp. 414-20
856 4 0 _uhttps://doi.org/10.1111/j.1365-2893.2005.00610.x
_zAvailable from publisher's website
999 _c15642362
_d15642362